Nanjing Shineking Biotech Co., Ltd.
PrivateLast Round
Series B
Extension
Sep 1, 2021
Est. Valuation
$29.85M
Total Funding Raised
$11.4M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Nanjing Shineking Biotech Co., Ltd. operates in Healthcare & Life Sciences and is based in Nanjing. Its latest recorded funding round was a Series B Extension round in September 2021.
Nanjing Shineking Biotech Co., Ltd. is a biotechnology company that develops and manufactures biopolymers, such as poly-amino acids and sugar alcohols, for use in the cosmetic, agricultural, food, and pharmaceutical industries.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Advanced Materials, Sustainable Materials, Fashion & Beauty
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Nanjing Shineking Biotech Co., Ltd. Comparables
Compare Nanjing Shineking Biotech Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Wuhan Guanghua Times Biotechnology Co., Ltd. | 80% | |
| Qingdao Bozhi Huili Biotechnology Co., Ltd. | 78% | |
| Wei Chuan Foods Corp | 76% |
For institutional investors. Book with your work email.
Nanjing Shineking Biotech Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B Extension | Sep 1, 2021 | ||||
| Series B | Jul 30, 2020 | ||||
| Series A Extension | Dec 1, 2017 | ||||
| Series A | Aug 1, 2017 | ||||
| Angel | Dec 1, 2015 |
For institutional investors. Book with your work email.
Nanjing Shineking Biotech Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Yuanhe Capital | Series B Extension |
| 金雨茂物投资管理股份有限公司 | Angel, Series A, Series B |
| 南京市创新投资集团有限责任公司 | Series B |
| Jiangsu Tianyou Investment Management | Series B, Series B Extension |
| Zhejiang Juesheng Investment Management | Series B |
| Addor Capital | Series B |
| Ennovation Ventures | Series B |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors increased 767% MoM, reaching 1.8K.
- Dec 20, 2024
Monthly visitors increased 111% MoM.
For institutional investors. Book with your work email.
Nanjing Shineking Biotech Co., Ltd. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Nanjing Shineking Biotech Co., Ltd.'s valuation, stock price, and market status.
Is Nanjing Shineking Biotech Co., Ltd. a public or private company?
Nanjing Shineking Biotech Co., Ltd. is a private company.
What is the current stock price of Nanjing Shineking Biotech Co., Ltd.?
Nanjing Shineking Biotech Co., Ltd. is a private company, so its shares have no public market price. Caplight tracks Nanjing Shineking Biotech Co., Ltd.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Nanjing Shineking Biotech Co., Ltd. worth (valuation)?
Nanjing Shineking Biotech Co., Ltd.'s valuation is estimated at $29.9M based on funding round data.
Can I buy Nanjing Shineking Biotech Co., Ltd. stock?
Nanjing Shineking Biotech Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Nanjing Shineking Biotech Co., Ltd.'s last funding round?
Nanjing Shineking Biotech Co., Ltd.'s most recent funding round was Series B Extension on September 1, 2021.
Who are the main investors in Nanjing Shineking Biotech Co., Ltd.?
Key investors in Nanjing Shineking Biotech Co., Ltd. include 金雨茂物投资管理股份有限公司.
Will Nanjing Shineking Biotech Co., Ltd. IPO soon?
No public IPO plans have been announced for Nanjing Shineking Biotech Co., Ltd..
How can I track Nanjing Shineking Biotech Co., Ltd. secondary market activity?
Caplight tracks bids, offers, and trades in Nanjing Shineking Biotech Co., Ltd.'s shares on secondary markets.